Ivan D. Horak
2006
In 2006, Ivan D. Horak earned a total compensation of $1.3M as M.D., Executive Vice President, Research and Development and Chief Scientific Officer at Enzon Pharmaceuticals.
Compensation breakdown
Non-Equity Incentive Plan | $300,000 |
---|---|
Option Awards | $357,398 |
Salary | $461,538 |
Stock Awards | $161,341 |
Other | $11,296 |
Total | $1,291,573 |
Horak received $461.5K in salary, accounting for 36% of the total pay in 2006.
Horak also received $300K in non-equity incentive plan, $357.4K in option awards, $161.3K in stock awards and $11.3K in other compensation.
Rankings
In 2006, Ivan D. Horak's compensation ranked 2,531st out of 7,022 executives tracked by ExecPay. In other words, Horak earned more than 64.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,531 | 64th |
Manufacturing | 776 | 68th |
Chemicals And Allied Products | 154 | 77th |
Drugs | 89 | 83rd |
Biological Products, Except Diagnostic Substances | 13 | 88th |
Horak's colleagues
We found four more compensation records of executives who worked with Ivan D. Horak at Enzon Pharmaceuticals in 2006.
2006
Jeffrey Buchalter
Enzon Pharmaceuticals
Chief Executive Officer
2006
Craig Tooman
Enzon Pharmaceuticals
Chief Financial Officer
2006
Ralph del Campo
Enzon Pharmaceuticals
Executive Vice President, Technical Operations
2006
Paul Davit
Enzon Pharmaceuticals